Company intelligence / Profile preview

Sustain Holdings

Bangalore, Karnataka, India

Ownership: Private
Development stage: Other

Overview

Sustain Therapeutics is a biotechnology company focused on developing long-acting, sustained-release injectable formulations for the treatment of chronic diseases. The company utilizes a proprietary hydrogel-based delivery platform to enable the controlled release of small molecules and peptides over several weeks to months. Their primary pipeline focuses on indications such as osteoarthritis pain and ophthalmic conditions like diabetic macular edema. By reducing the frequency of injections, Sustain Therapeutics aims to improve patient compliance and therapeutic outcomes in chronic care settings.

Therapeutic areas: OphthalmologyNeurologyRheumatology
Modalities: Small moleculePeptidesHydrogel-based drug delivery therapy
Industry: Biotech

Beyond the preview

Go deeper on Sustain Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sustain Holdings.

Explore the full profile